Myriad Genetics stock hits 52-week low at $9.36 amid challenges#Myriad #Genetics #stock #hits #52week #challenges
Tag: Myriad
New study highlights effectiveness and cost benefits of Myriad™ in lower limb salvage surgeries. By Investing.com
AUCKLAND, New Zealand, Jan. 16, 2025 /PRNewswire/ — New Zealand headquartered soft tissue regeneration company Aroa…